Each product team defends its roadmap
Portfolio Allocation
Move capital across the portfolio, not only inside one product.
See which investments deserve more, less, or nothing this cycle — with capacity and outcome lineage attached.
Problem
Portfolio reviews summarize status. They rarely reopen the original bet: why this product still receives this share of capital.
Current fragmented workflow
Finance rolls up spend after the fact
Capacity is assumed to be infinitely divisible
Last year’s allocation is the default
How BrumeIQ changes it
BrumeIQ places products in one investment conversation: economics, market pressure, existing capability and the enterprise’s ability to execute.
Example decision
Two products request incremental investment. One has weakening evidence and high capacity contention. The other has a clearer predicted outcome and unused adjacent capability.
Portfolio health · Capital already committed · Predicted vs prior outcomes · Shared capacity
Reallocate · Hold both · Reduce one · Do nothing this cycle
Allocation becomes a decision with memory, not a once-a-year spreadsheet.
The next investment decision shouldn’t start with another dashboard.
Start with the evidence. Understand the alternatives. Decide where investment belongs.